Logo

University of Memphis Receives $1 Million Grant To Establish Bioinformatics Program

Aug 20, 2004

NEW YORK, Aug. 20 (GenomeWeb News) - Universityof Memphisofficials said today that the university has received a $1 million grant from a philanthropic foundation to establish a Master's program in bioinformatics.

 

"Bioinformatics is critical for a lot of research that's being done in the biological sciences," said Ralph Faudree, the provost of the university. "We want to have a program that's interdisciplinary. It will be a changing and upgrading of the current bioinformatics concentration within the computer science department."

 

Funds for the new program were granted by the Assisi Foundation, a philanthropic organization that supports healthcare issues and scientific research.

 

Faudree said the university will use the money to hire a chairman for the bioinformatics program and two new faculty, as well as graduate assistants and guest lecturers. The university is currently in the process of recruiting the chairman and new faculty members for the program.

 

Ultimately, the bioinformatics department will probably include several faculty from the biology department, two faculty from the computer science program and one faculty member who specializes in math sciences, Faudree said.

 

 

 

Breaking News
The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.